 | • レポートコード：QYR9ST04401 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、骨・ミネラル代謝障害治療の世界市場について調査・分析し、骨・ミネラル代謝障害治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ビスホスホネート、エストロゲン、リン酸バインダー、非カルシウム・非金属ベースバインダー、金属ベースバインダー、マグネシウムベースバインダー、ビタミンD類縁体・サプリメント、カルシウム擬態薬、カルシウム・マグネシウムサプリメント）、用途別（病院薬局、小売薬局、オンライン薬局、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の骨・ミネラル代謝障害治療市場動向 ・主要企業別マーケットシェア ・骨・ミネラル代謝障害治療の種類別市場規模2014-2019 （ビスホスホネート、エストロゲン、リン酸バインダー、非カルシウム・非金属ベースバインダー、金属ベースバインダー、マグネシウムベースバインダー、ビタミンD類縁体・サプリメント、カルシウム擬態薬、カルシウム・マグネシウムサプリメント） ・骨・ミネラル代謝障害治療の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局、ドラッグストア） ・骨・ミネラル代謝障害治療の北米市場：主要企業・種類別/用途別市場規模 ・骨・ミネラル代謝障害治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・骨・ミネラル代謝障害治療の中国市場：主要企業・種類別/用途別市場規模 ・骨・ミネラル代謝障害治療の日本国内市場：主要企業・種類別/用途別市場規模 ・骨・ミネラル代謝障害治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・骨・ミネラル代謝障害治療のインド市場：主要企業・種類別/用途別市場規模 ・骨・ミネラル代謝障害治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Merck、F. Hoffmann-La Roche、Novartis、Warner Chilcott、Sanofi、AbbVie、Amgen） ・骨・ミネラル代謝障害治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone remodelling process. Bone functions as storehouse of calcium, from which calcium is continuously withdrawn or stored as a part of homeostasis. Bone mineral metabolism is refers to the maintenance of sufficient concentration of inorganic ions in blood serum irrespective of muscle tissue metabolic activities. Hormones such as parathormone and calcitonin plays vital role in controlling the muscle metabolic activities, these hormones are regulated by neuroendocrine system and produced by parathyroid and thyroid glands in the neck. Malfunction of these glands result in to metabolic in equilibrium and crates the problems of bone mineral metabolism. Bone and mineral density metabolic disorders are abnormalities of bones, caused by calcium, phosphorous, magnesium and vitamin D aberrations leading to several reversible clinical disorders. These disorders are generally treatable if the underlining cause is addressed with corrective treatment methods. These disorders are caused due to genetic or metabolic malfunctions in the body.Global bone and mineral metabolism disorders treatment market is undergoing market changes due to the higher competition among local and multinational players and this in turn helped to make treatment cost more economical. With the availability of wide variety of products in various forms and strengths in the bone and mineral metabolism disorders treatment market is expected to change the market dynamics over a given period of forecast. By disease type, sub segment such as osteoporosis and rickets in the global bone and mineral metabolism disorders treatment market are expected to grow in positive traction owing to increased prevalence of the diseases among the post-menopausal women and children in the various regions.
In 2018, the global Bone and Mineral Metabolism Disorders Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Bone and Mineral Metabolism Disorders Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bone and Mineral Metabolism Disorders Treatment development in United States, Europe and China.
The key players covered in this study
Merck
F. Hoffmann-La Roche
Novartis
Warner Chilcott
Sanofi
AbbVie
Amgen
…
Market segment by Type, the product can be split into
Bisphosphonates
Estrogens
Phosphate Binders
Non-Calcium, Non-Metal-Based Binder
Metal-Based Binders
Magnesium-Based Binders
Vitamin D Analogs and Supplements
Calcimimetic Agents
Calcium and Magnesium Supplements
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Bone and Mineral Metabolism Disorders Treatment status, future forecast, growth opportunity, key market and key players.
To present the Bone and Mineral Metabolism Disorders Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Bone and Mineral Metabolism Disorders Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bone and Mineral Metabolism Disorders Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Bisphosphonates
1.4.3 Estrogens
1.4.4 Phosphate Binders
1.4.5 Non-Calcium, Non-Metal-Based Binder
1.4.6 Metal-Based Binders
1.4.7 Magnesium-Based Binders
1.4.8 Vitamin D Analogs and Supplements
1.4.9 Calcimimetic Agents
1.4.10 Calcium and Magnesium Supplements
1.5 Market by Application
1.5.1 Global Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Bone and Mineral Metabolism Disorders Treatment Market Size
2.2 Bone and Mineral Metabolism Disorders Treatment Growth Trends by Regions
2.2.1 Bone and Mineral Metabolism Disorders Treatment Market Size by Regions (2014-2025)
2.2.2 Bone and Mineral Metabolism Disorders Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Bone and Mineral Metabolism Disorders Treatment Market Size by Manufacturers
3.1.1 Global Bone and Mineral Metabolism Disorders Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Bone and Mineral Metabolism Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Bone and Mineral Metabolism Disorders Treatment Key Players Head office and Area Served
3.3 Key Players Bone and Mineral Metabolism Disorders Treatment Product/Solution/Service
3.4 Date of Enter into Bone and Mineral Metabolism Disorders Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2014-2019)
4.2 Global Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Bone and Mineral Metabolism Disorders Treatment Market Size (2014-2019)
5.2 Bone and Mineral Metabolism Disorders Treatment Key Players in United States
5.3 United States Bone and Mineral Metabolism Disorders Treatment Market Size by Type
5.4 United States Bone and Mineral Metabolism Disorders Treatment Market Size by Application
6 Europe
6.1 Europe Bone and Mineral Metabolism Disorders Treatment Market Size (2014-2019)
6.2 Bone and Mineral Metabolism Disorders Treatment Key Players in Europe
6.3 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Type
6.4 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Application
7 China
7.1 China Bone and Mineral Metabolism Disorders Treatment Market Size (2014-2019)
7.2 Bone and Mineral Metabolism Disorders Treatment Key Players in China
7.3 China Bone and Mineral Metabolism Disorders Treatment Market Size by Type
7.4 China Bone and Mineral Metabolism Disorders Treatment Market Size by Application
8 Japan
8.1 Japan Bone and Mineral Metabolism Disorders Treatment Market Size (2014-2019)
8.2 Bone and Mineral Metabolism Disorders Treatment Key Players in Japan
8.3 Japan Bone and Mineral Metabolism Disorders Treatment Market Size by Type
8.4 Japan Bone and Mineral Metabolism Disorders Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size (2014-2019)
9.2 Bone and Mineral Metabolism Disorders Treatment Key Players in Southeast Asia
9.3 Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size by Type
9.4 Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size by Application
10 India
10.1 India Bone and Mineral Metabolism Disorders Treatment Market Size (2014-2019)
10.2 Bone and Mineral Metabolism Disorders Treatment Key Players in India
10.3 India Bone and Mineral Metabolism Disorders Treatment Market Size by Type
10.4 India Bone and Mineral Metabolism Disorders Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size (2014-2019)
11.2 Bone and Mineral Metabolism Disorders Treatment Key Players in Central & South America
11.3 Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size by Type
11.4 Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size by Application
12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bone and Mineral Metabolism Disorders Treatment Introduction
12.1.4 Merck Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
12.1.5 Merck Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bone and Mineral Metabolism Disorders Treatment Introduction
12.2.4 F. Hoffmann-La Roche Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bone and Mineral Metabolism Disorders Treatment Introduction
12.3.4 Novartis Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Warner Chilcott
12.4.1 Warner Chilcott Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bone and Mineral Metabolism Disorders Treatment Introduction
12.4.4 Warner Chilcott Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
12.4.5 Warner Chilcott Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bone and Mineral Metabolism Disorders Treatment Introduction
12.5.4 Sanofi Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Bone and Mineral Metabolism Disorders Treatment Introduction
12.6.4 AbbVie Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 Amgen
12.7.1 Amgen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Bone and Mineral Metabolism Disorders Treatment Introduction
12.7.4 Amgen Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
12.7.5 Amgen Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Bone and Mineral Metabolism Disorders Treatment Key Market Segments
Table Key Players Bone and Mineral Metabolism Disorders Treatment Covered
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Size Market Share by Type 2014-2025
Figure Bisphosphonates Figures
Table Key Players of Bisphosphonates
Figure Estrogens Figures
Table Key Players of Estrogens
Figure Phosphate Binders Figures
Table Key Players of Phosphate Binders
Figure Non-Calcium, Non-Metal-Based Binder Figures
Table Key Players of Non-Calcium, Non-Metal-Based Binder
Figure Metal-Based Binders Figures
Table Key Players of Metal-Based Binders
Figure Magnesium-Based Binders Figures
Table Key Players of Magnesium-Based Binders
Figure Vitamin D Analogs and Supplements Figures
Table Key Players of Vitamin D Analogs and Supplements
Figure Calcimimetic Agents Figures
Table Key Players of Calcimimetic Agents
Figure Calcium and Magnesium Supplements Figures
Table Key Players of Calcium and Magnesium Supplements
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Drug Stores Case Studies
Figure Bone and Mineral Metabolism Disorders Treatment Report Years Considered
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size 2014-2025 (Million US$)
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions 2014-2019
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions 2014-2019
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Bone and Mineral Metabolism Disorders Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Bone and Mineral Metabolism Disorders Treatment Market Share by Manufacturers (2014-2019)
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Share by Manufacturers in 2018
Table Global Bone and Mineral Metabolism Disorders Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Bone and Mineral Metabolism Disorders Treatment Product/Solution/Service
Table Date of Enter into Bone and Mineral Metabolism Disorders Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size Share by Type (2014-2019)
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Size Market Share by Type (2014-2019)
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size Share by Application (2014-2019)
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Size Market Share by Application (2014-2019)
Figure Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Application in 2018
Figure United States Bone and Mineral Metabolism Disorders Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2018-2019)
Table United States Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2014-2019)
Table United States Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2014-2019)
Figure Europe Bone and Mineral Metabolism Disorders Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2018-2019)
Table Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2014-2019)
Table Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2014-2019)
Figure China Bone and Mineral Metabolism Disorders Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2018-2019)
Table China Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2014-20189) (Million US$)
Table China Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2014-2019)
Table China Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table China Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2014-2019)
Figure Japan Bone and Mineral Metabolism Disorders Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2018-2019)
Table Japan Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2014-2019)
Table Japan Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2018-2019)
Table Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2014-2019)
Table Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2014-2019)
Figure India Bone and Mineral Metabolism Disorders Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2018-2019)
Table India Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table India Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2014-2019)
Table India Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table India Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2014-2019)
Figure Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Bone and Mineral Metabolism Disorders Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Bone and Mineral Metabolism Disorders Treatment Market Share (2018-2019)
Table Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2014-2019)
Table Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
Table Merck Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
Table Novartis Recent Development
Table Warner Chilcott Company Details
Table Warner Chilcott Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)(Million US$)
Figure Warner Chilcott Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
Table Warner Chilcott Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
Table Sanofi Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Amgen Company Details
Table Amgen Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2014-2019)
Table Amgen Recent Development
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Size Share by Regions (2019-2025)
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Size Share by Regions in 2025
Figure United States Bone and Mineral Metabolism Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Bone and Mineral Metabolism Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Bone and Mineral Metabolism Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Bone and Mineral Metabolism Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Bone and Mineral Metabolism Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Bone and Mineral Metabolism Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Size by Product (2019-2025)
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Size by Product in 2025
Table Global Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2019-2025)
Figure Global Bone and Mineral Metabolism Disorders Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ラテックスバインダー及びコーティングの世界市場：市場規模・現状・予測 In 2018, the global Latex Binders & Coatings market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Latex Binders & Coatings status, future forecast, growth opportunity, key market and key p…- ラテックスバインダー及びコーティングの世界市場：市場規模・現状・予測 In 2018, the global Latex Binders & Coatings market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Latex Binders & Coatings status, future forecast, growth opportunity, key market and key p…
- 世界のアクリルバインダー市場：専門的調査 Acrylic Binders are used for the production and formulation of paints, adhesives, sealants, construction and fibre bonding materials and in the paper and packaging industry. The global Acrylic Binders market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growi…
- マイコトキシンバインダーの世界市場：インサイト・予測 Mycotoxin binders are routinely added in such cases as safety measures and as some form of assurance to customers. A variety of substances have the ability to bind mycotoxins. The most commonly used and most researched mycotoxin-binding agents are the aluminosilicates – clays and zeolites.Leading co…
- ブランクブック・ルーズリーフバインダー・その他の製品の世界市場：インサイト・予測 Blankbook is a kind of note book. And looseleaf binder is a another kind of notebook which the paper can be removed flexibly because the paper usually unsealed in the notebook. Loose leaves may be sold as free sheets, or made up into notepads, where perforations allow them to be removed easily.The g…